We Must Deal Realistically With Fraud and Error

Several years ago Patricia Woolf; a respected sociologist of science whose specialty is misconduct, testified before Congress that scientists who observe scientific misconduct not only have an obligation to report the mis- conduct, but that failure to do so would plactheir careers in jeopardy. She said that there are “considerable penalties” for the “scientist who knows but doesn’t tell.” The facts suggest otherwise. In this. issue of THE SCIENTIST, three scient

Written byWalter Stewart
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Several years ago Patricia Woolf; a respected sociologist of science whose specialty is misconduct, testified before Congress that scientists who observe scientific misconduct not only have an obligation to report the mis- conduct, but that failure to do so would plactheir careers in jeopardy. She said that there are “considerable penalties” for the “scientist who knows but doesn’t tell.”

The facts suggest otherwise. In this. issue of THE SCIENTIST, three scientists describe what happened when they reported incidents of misconduct—allegations that eventually were shown to be true. In each case the institutions involved ignored the allegations for long periods of time, while the scientist reporting the misconduct suffered personal criticism, professional retaliation and financial loss.

It is quite clear from cases like these that the subject of scientific misconduct makes most scientists uncomfortable. Ask them how they feel about misconduct, and chances are they will condemn it strongly. But present ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies